Today: 11 November 2025
Subscribe

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Medical Properties Trust Defies Skeptics: Q3 Beat and Buyback Ignite 6%‑Yield REIT Rally

Medical Properties Trust Defies Skeptics: Q3 Beat and Buyback Ignite 6%‑Yield REIT Rally

Q3 Earnings Surprise and Portfolio Updates Medical Properties Trust’s third-quarter results provided a dose of relief for investors who have endured a turbulent year. Normalized FFO came in at $0.13 per share, comfortably ahead of what many analysts had expected (consensus was near $0.08, with some forecasts as low as essentially breakeven) chartmill.com. This key profit metric for REITs was down from $0.16 a year ago businesswire.com, reflecting ongoing challenges, but the “beat” versus expectations drew focus. “Investors responded positively to the earnings beat and management’s optimistic commentary,” noted ChartMill, after MPW shares rose about 2–3% in pre-market trading on
30 October 2025
 ·  ·  ·  ·  · 
Harvard Bioscience (HBIO) Plunges 84% – Will New CEO & Nasdaq Lifeline Spark a Turnaround?

Harvard Bioscience (HBIO) Plunges 84% – Will New CEO & Nasdaq Lifeline Spark a Turnaround?

HBIO Stock in Freefall – and a Nasdaq Lifeline Harvard Bioscience’s share price has been on a wild ride in 2025, mostly downhill. The stock now hovers around 40 cents, down from the mid-$2 range a year ago fintel.io. In fact, HBIO has lost nearly 84% of its value year-over-year fintel.io, an astonishing collapse that reflects both company-specific struggles and the broader market rout in small-cap biotech names. Shares cratered to an intraday low of $0.28 in mid-2025 amid intense selling pressure investing.com, before staging a modest rebound. Even after some recovery, HBIO remains deep in penny stock territory, a
30 October 2025
 ·  ·  ·  ·  · 
Plug Power’s 170% Hydrogen Rally Cools – Can PLUG Stock Reignite?

Plug Power’s 170% Hydrogen Rally Cools – Can PLUG Stock Reignite?

Roller-Coaster Stock Ride in October Plug Power’s stock has been on a wild ride through October. After languishing around $1.50 per share in late summer 2025, PLUG erupted in a hydrogen-fueled rally, reaching a new 52-week high near $4.58 by early October ts2.tech. That surge – roughly +170% in a few months – vastly outpaced the broader market. It was amplified by a short squeeze: with roughly one-third of PLUG’s float sold short, each burst of positive news forced bearish traders to buy shares to cover, turbocharging the uptrend ts2.tech. Indeed, PLUG logged nearly 100 trading days with swings over
30 October 2025
 ·  ·  ·  ·  · 
Intel (INTC) Stock Soars 90% to 18-Month High on AI Boom, $15B Lifeline – Will the Rally Last?

Intel (INTC) Stock Soars 90% to 18-Month High on AI Boom, $15B Lifeline – Will the Rally Last?

Stock Soars to Multi-Year High on Turnaround Hopes Intel shares are in the midst of a dramatic comeback in 2025, riding a wave of optimism that the once-struggling chipmaker can regain its footing in the AI era. Year-to-date, INTC has surged roughly 90%, marking one of the best performances in the semiconductor sector this year ts2.tech ts2.tech. By late October, the stock was trading around $40–$42 – levels not seen in about two years – after nearly doubling from its January lows of around $20 ts2.tech tradingnews.com. This torrid rally has significantly outpaced the broader market (the S&P 500 is
30 October 2025
 ·  ·  ·  ·  · 
Ambev’s Profit Soars 36% in Q3 – Buyback Announced as ABEV Stock Eyes Rally

Ambev’s Profit Soars 36% in Q3 – Buyback Announced as ABEV Stock Eyes Rally

Q3 Earnings: Big Profit Beat and New Buyback São Paulo-based Ambev delivered a stronger-than-expected third quarter, defying the industry’s mixed outlook. Net profit leapt to R$4.86 billion (~$899 million) reuters.com, a 36% increase from a year ago. This result blew past analysts’ consensus of roughly R$3.2 billion reuters.com, reflecting robust operational performance. On a per-share basis, earnings were approximately $0.06 (USD) for the quarter – significantly higher than estimates around $0.04. Management credited “disciplined” cost and expense management for shoring up profitability reuters.com. In an environment of rising input costs, Ambev managed to expand its EBITDA margin slightly, demonstrating effective
30 October 2025
 ·  ·  ·  ·  · 
FMC Stock Plunges Over 40% to Multi-Year Low After Shock Loss and Dividend Cut – Is a Turnaround Possible?

FMC Stock Plunges Over 40% to Multi-Year Low After Shock Loss and Dividend Cut – Is a Turnaround Possible?

Earnings Shock: Huge Loss on India Exit and Plunging Sales FMC Corporation stunned the market with a far worse-than-expected third quarter, driven by a massive one-time hit in its international operations. The Philadelphia-based crop protection company reported a GAAP net loss of $569.3 million for Q3 2025, a dramatic swing from a $65 million profit in the same quarter last year benzinga.com. The red ink stems largely from FMC’s troubled India business, which the firm is preparing to divest. FMC took a $510 million write-down on the India unit’s value and associated assets, writing its carrying value down from about $960 million to $450 million benzinga.com.
30 October 2025
 ·  ·  ·  ·  · 
Conduent’s Ticket Machine Revolution Debuts in Italy Amid Data Breach Fallout and Market Buzz

Conduent’s Ticket Machine Revolution Debuts in Italy Amid Data Breach Fallout and Market Buzz

Conduent Launches Next-Gen Ticket Kiosk in Italy Conduent’s DOT1 ticket vending machine, now deployed by Italy’s SETA S.p.A., features a multimedia touch-screen interface and supports contactless payments, real-time travel info, and cross-service ticketing businesswire.com. Conduent Business Solutions is making headlines in Europe with the debut of its DOT1 ticket vending machine – a fully digital transit kiosk – now officially in service in Italy. SETA S.p.A., the public transport operator for the provinces of Modena, Reggio Emilia, and Piacenza, has become the first to install and use the next-generation Conduent DOT1 kiosk businesswire.com. This implementation is viewed as a significant
30 October 2025
 ·  ·  ·  ·  · 
Nvidia’s Record $5 Trillion Surge: AI Mega-Deals Propel NVDA Stock – Is $300 Next?

Nvidia’s Record $5 Trillion Surge: AI Mega-Deals Propel NVDA Stock – Is $300 Next?

NVDA Stock at Record Highs Amid AI Frenzy Nvidia’s stock has been on a tear in late 2025, repeatedly flirting with all-time highs. Shares closed at about $207 on Oct. 29, a new record that put Nvidia’s market capitalization around $5.03 trillion reuters.com. This milestone makes Nvidia the first company ever to reach a $5 trillion valuation, underscoring how dramatically it has ascended on the back of the AI boom reuters.com. Year to date, NVDA is up roughly 30%, vastly outperforming the S&P 500 index’s gains ts2.tech. The stock has now leaped about 58% from one year ago and stands nearly 12×
30 October 2025
 ·  ·  ·  · 
Crocs Stock Soars on Surprise Earnings Beat – Can the ‘Ugly Shoe’ Icon Stage a Comeback?

Crocs Stock Soars on Surprise Earnings Beat – Can the ‘Ugly Shoe’ Icon Stage a Comeback?

Strong Q3 Results Spark a Stock Surge Crocs (CROX) stock jumped over 7% on Thursday after the foam-footwear maker reported better-than-expected third-quarter earnings stockstory.org. The company’s Q3 revenue of $996.3 million, though down 6.2% from a year ago, beat analyst estimates by about 3% stockstory.org. Adjusted net income came in at $2.92 per share, trouncing forecasts (23.7% above consensus) and indicating Crocs managed to outperform in a tough environment stockstory.org. Management also surprised the market with an upbeat outlook for the holiday quarter: Q4 revenue is projected around $1.07 billion, roughly 15% higher than Wall Street’s expectation, along with solid
30 October 2025
 ·  ·  ·  ·  · 
Bristol Myers Squibb (NYSE:BMY) Surges on Q3 Earnings Beat and Raised Outlook – What’s Next for BMY Stock?

Bristol Myers Squibb (NYSE:BMY) Surges on Q3 Earnings Beat and Raised Outlook – What’s Next for BMY Stock?

BMY Stock Bounces After Earnings – Recent Performance Bristol Myers Squibb’s stock has been under pressure for most of 2025, but the Q3 report provided a much-needed boost. Heading into earnings, BMY shares were near 52-week lows, reflecting investor skittishness over looming patent cliffs and mixed news in prior quarters. In fact, on October 28, the stock touched a one-year low of $42.96 (closing at $42.99) marketbeat.com. That put BMY down roughly 18–19% year-to-date, significantly underperforming the pharma sector (which was roughly flat to slightly up over the same period) nasdaq.com. By comparison, an index of large pharmaceutical stocks was
30 October 2025
 ·  ·  ·  · 
Altria Stock Slips After Mixed Q3 Earnings – Big Buyback and 8% Dividend Tempt Investors

Altria Stock Slips After Mixed Q3 Earnings – Big Buyback and 8% Dividend Tempt Investors

MO Stock Slides on Mixed Earnings Altria’s third-quarter earnings highlight the tobacco giant’s balancing act between resilient profits and declining cigarette usage. The company reported an adjusted Q3 profit of $1.45 per share, a 3.6% increase year-on-year and exactly in line with analyst expectations reuters.com. However, revenue fell more than anticipated – net revenues came in at $6.07 billion, down ~3% from a year ago reuters.com. This topline drop exceeded Wall Street’s forecasts and underscored weaker cigarette volumes. The mixed results put immediate pressure on MO stock, which fell about 4% ahead of Thursday’s open on the news reuters.com. Even after
30 October 2025
 ·  ·  ·  ·  · 
Cava Stock Plunges to 52-Week Low – Bargain Buy or More Pain Ahead?

Cava Stock Plunges to 52-Week Low – Bargain Buy or More Pain Ahead?

Stock Hits a Record Low Cava’s stock has been on a steep slide since its euphoric post-IPO highs. This week, shares tumbled to $54.93, their lowest level in a year za.investing.com. That price is well under half of where CAVA traded 12 months ago za.investing.com, and a far cry from the ~$170 peak the market once ascribed to this high-flying restaurant IPO. In fact, the stock now sits roughly 62% below its peak levels reached after its 2023 IPO ts2.tech. The 52-week high of $172.43 underscores how dramatically sentiment has reversed za.investing.com. What’s driving the collapse? Broad market volatility and
30 October 2025
 ·  ·  ·  ·  · 
1 … 33 34 35 36 37 … 175
Go toTop